Nitric oxide (NO) has antimicrobial activity against a wide spectrum of infectious pathogens, but an antiviral effect has not been reported. The impact of NO, from endogenous and exogenous sources, on herpes simplex virus type 1 (HSV 1) replication was studied in vitro. HSV 1 replication in RAW 264.7 macrophages was reduced 1,806-fold in monolayers induced to make NO by activation with gamma IFN and LPS. A competitive and a noncompetitive inhibitor of nitric oxide synthetase substantially reduced the antiviral effect of activated RAW macrophages. S-nitroso-L-acetyl penicillamine (SNAP) is a donor of NO and was added to the media of infected monolayers to assess the antiviral properties of NO in the absence of gamma IFN and LPS. A single dose of S-nitroso-L-acetyl penicillamine 3 h after infection inhibited HSV 1 replication in Vero, HEp2, and RAW 264.7 cells in a dosedependent manner. Neither virucidal nor cytocidal effects of NO were observed under conditions that inhibited HSV 1 replication. Nitric oxide had inhibitory effects, comparable to that of gamma IFN/LPS, on protein and DNA synthesis as well as on cell replication. This report demonstrates that, among its diverse properties, NO has an antiviral effect.
Introduction
Herpes simplex viruses (HSV)' types 1 and 2 are extremely prevalent infections of mankind. Primary infection at the site of inoculation is accompanied by infection in the corresponding sensory and autonomic ganglia where latent infections are established. These dormant foci serve as reservoirs for future reactivation infections with HSV ( 1, 2). Although HSV encodes many genes that contribute to its neuropathogenesis (3, 4) , the host response has a marked influence on the outcome of wild-type infections. Our understanding ofthe viral-host interactions that orchestrate the downregulation of lytic infections, 1 . Abbreviations used in this paper: DPI, diphenylenediodonium; HSV, herpes simplex virus; Mo, macrophage; L-NMMA, N0-monomethyl-L-arginine; NO, nitric oxide; NOS, NO synthetase; pfu, plaqueforming units; SNAP, S-nitroso-L-acetyl penicillamine. prevent widespread dissemination, and promote the latent state, is incomplete.
Both innate and acquired immune responses are fundamental components ofa successful host response to HSV infection. Impaired cellular immune function predisposes to severe primary and recurrent HSV infections (1) . The humoral immune response to HSV facilitates antibody-dependent cell-mediated cytotoxicity and neutralizes cell-free virions with both type-specific and cross-reacting antibodies (5, 6) . Macrophages and natural killer cells are primary mediators of innate host defense mechanisms. Defects in the ability ofthese leukocytes to destroy cells productively infected with HSV contributes to the overwhelming infection that is characteristic of HSV infection in neonates (7) (8) (9) . Other nonspecific host responses to infection, in particular the production ofinterleukin 2, tumor necrosis factor-a, and interferons, augment the protective functions of macrophages and natural killer cells, and may act directly on infected cells to suppress HSV infection (10) (11) (12) .
Nitric oxide (NO) is a free radical gaseous molecule that is a mediator of vital physiologic functions, including host defense (13) (14) (15) (16) . Many cell types are able to produce NO through the enzymatic conversion of L-arginine to L-citrulline by nitric oxide synthetase (NOS). Neurons, endothelial cells, and macrophages are the best characterized sources of NO. From these sites of production, NO modulates neuronal function, regulates vasomotor tone, and is involved in host responses to infection (13) (14) (15) (16) . NO and related reactive nitrogen intermediates exert microbistatic and microbicidal effects against a variety of pathogens, including protozoans, flukes, fungi, and bacteria (16) (17) (18) (19) (20) (21) . To date, however, antiviral properties of NO have not been described. The purpose of these studies was to determine whether NO inhibits HSV 1 replication in vitro.
Methods
Cells and viruses. The RAW 264.7 cell line (TIB 71; American Type Culture Collection, Rockville, MD) is a murine macrophage transformed with the Abelson leukemia virus that produces NO when stimulated with murine -yIFN and/or LPS. These cells were maintained in DMEM (high glucose) supplemented with 10% heat denatured fetal calf serum (Hyclone Laboratories Inc., Logan, UT), penicillin G (100 U/ml), and streptomycin (100 gg/ml). Vero Cell replication was studied in the presence of SNAP, penicillamine, or media alone by performing cell counts in a hemocytometer on trypsinized monolayers 24, 48, and 72 h after plating Vero and RAW cells in low density (1 X 105 cells/well). The effect of yIFN (50 U/ml) and LPS (50 ng/ml) on RAW MO replication also was investigated. In all cases, reagents were removed from the cell culture media after the first 24-h incubation.
Results
HSV I replication and nitric oxide production in RA W
MO
As a first step to determine whether NO inhibits HSV 1 replication, the ability of HSV 1 to replicate in a cell line that can be stimulated to produce NO was investigated. The RAW 264.7
MO has been used widely in studies of inducible NO production and, therefore, was selected for the studies that follow.
Confluent monolayers of RAW MO were inoculated with HSV 1 (moi 0.1 ) and then incubated in medium 199 with or without 'yIFN (50 U/ml) and LPS (50 ng/ml). The results of eight experiments are summarized in Table I . HSV 1 replicated to high titer within 24 h ofinoculation in unstimulated control monolayers. Minimal quantities ofNO were produced in these monolayers. In contrast, viral replication was dramatically de- Is an alternative arginine-dependent pathway involved in suppressing HSV replication in cells exposed to yIFN and LPS?
Definitive assignment of the antiviral arginine-dependent pathway to the production ofNO assumes that other metabolic effects of arginine do not result in the inhibition of HSV 1 replication. To explore the possibility that arginine may be im- The effect of nitric oxide from an exogenous source on HSV I replication 'yIFN and LPS induce a wide range of metabolic effects within macrophages that contribute to their ability to inhibit HSV 1 replication (28, 29) . An exogenous source of NO eliminates the need for yIFN/LPS and thereby permits a more direct assessment of the potential antiviral effects of NO. Several compounds that release NO (NO donors) have been described (23, 30) . SNAP, the nitrosylated form of L-acetyl penicillamine, donates NO when placed in an aqueous solution (23) . The effect ofthis compound on HSV 1 replication was investigated. Confluent monolayers of Vero cells were inoculated with HSV 1 (moi 0.1 ) and, at several times thereafter, freshly prepared solutions of SNAP (500 MM) or media alone were added to the cultures. In three experiments, a greater antiviral effect was consistently observed when SNAP was added to the media 3 h after inoculation than when added immediately after the 1-h adsorption. The mean fold reductions were 105±54 when added at 3 h, and 22±4.3 when added at 0 h (in each case P < 0.02 vs control; P = 0.06 comparing fold reduction at 3 h vs. 0 h; by a paired t test). SNAP was added 3 h after inoculation in all subsequent studies. Dose response studies were performed in RAW MO, Vero cells, and HEp2 cells infected with HSV 1 (moi 0.1 ). As shown in Fig. 3 of 160±61-fold in Vero cells (n = 9) and 30± 10-fold in HEp2 cells (n = 6). At 250MM SNAP, HSV 1 replication was reduced 101±38-fold in Vero cells (n = 10) and 15±1.9-fold in RAW MO (n = 3). In each case, the titers ofthe SNAP-treated monolayers were significantly different from the controls (P < 0.05 by a paired t test). Penicillamine controls were included in most experiments and, in each case, titers were virtually identical to untreated controls (data not shown).
Potential mechanisms ofthe antiviral effect ofNO Studies on the virucidal activity ofSNAP and yIFN/LPS. The possibility that SNAP or 7IFN/LPS mediated their antiviral effects by destroying the infectivity of whole virions was investigated. As shown in Fig. 4 , this proved not to be the case. HSV 1 was incubated for 5 h at 370C in media alone, or media supplemented with SNAP (500 MM), L-acetyl penicillamine (500 MM), yIFN (100 U/ml) and LPS (100 ng/ml), or 10% ethanol. While 10% ethanol was predictably virucidal, none of the other reagents caused an acceleration in the loss of viral infectivity.
Cytotoxicity ofnitric oxide. The antiviral activity associated with NO also could be secondary to its well-recognized cytotoxic properties (31 ) . Several approaches were taken to evaluate the effects of NO on cellular metabolism and viability. The Hours of incubation be relevant to its antiviral activity is its effect on cell division (31) . Vero cells were plated at low density (1 X IO1 cells/well of a 12-well plate) and incubated with or without SNAP. After 24 h, the monolayers were trypsinized and the cell density quantified in a hemocytometer. SNAP-treated wells contained 48% (250 gM) and 60% (500 gM) fewer cells than the untreated controls (n = 6 for each group). However, cell viability determined by ethidium bromide staining prior to scraping was not altered by SNAP (> 99% viable in all wells). Fresh media without SNAP was placed on the remaining wells after the 24-h incubation and cell replication was monitored. Over the subsequent 48 h, the cell density in SNAP-treated wells approached that of untreated controls (87% of controls). Similar results were obtained with RAW MO and HEp2 cells incubated with SNAP as well as RAW MO activated with -yIFN (50 U/ml) and LPS (50 ng/ml). The addition of 250 ,gM L-NMMA to activated RAW MO did not alleviate the inhibition of cell replication induced by yIFN/LPS (data not shown). Cell replication in media containing 500,gM penicillamine was almost identical to the untreated control. In addition to these metabolic studies, the impact ofNO on cell viability was investigated. The viability of uninfected and HSV 1-infected RAW MO was monitored by ethidium bromide exclusion in the presence or absence of yIFN and LPS. 24 h after activation ofuninfected RAW cells, viability was identical to that of unactivated controls (96-99%). The media containing yIFN and LPS was replaced with fresh media alone after 24 h. More than 98% of activated and unactivated RAW MO remained viable 48 and 72 h after activation. A similar result was obtained in HSV 1-infected monolayers activated with yIFN and LPS immediately after inoculation (moi 0.1). Both 24 and 36 h after infection, ethidium bromide staining revealed almost identical viability ofactivated and unactivated monolayers: 94% (both activated and unactivated) at 24 h; 85% (activated) and 82% (unactivated) at 36 h (n = 4 for each group at each time point). The 1,806-fold reduction in viral titer from activated RAW MO (Table I ) therefore, cannot be explained by an excess of cell death in these monolayers.
Several observations suggest that cytocidal properties of SNAP did not contribute to its antiviral effect. First, the viability of each cell line (Vero, HEp2, and RAW MO) was maintained (> 99%) for up to 48 h after a 24-h incubation with SNAP (500 AM for Vero and HEp2; 250 ,uM for RAW M+).
Secondly, the viability of infected monolayers also was unaffected by the presence of SNAP. 24 h after infection, 98% of SNAP-treated (500 tiM) Vero cells excluded ethidium bromide as opposed to 99% of untreated controls. Finally, the antiviral effect was greater when SNAP was added 3 h after inoculation rather than when it was added immediately afterward. If a cytotoxic effect of NO was responsible for the reduction in HSV 1 replication, then a more potent inhibitory effect would have been likely with the addition ofSNAP immediately after inoculation.
Discussion
Nitric oxide is being recognized increasingly as an important component ofthe host response to infection (16) (17) (18) (19) (20) (21) . NO modulates immune responses by mediating the regulation of lymphocyte proliferation by suppressor macrophages (32) . Furthermore, it influences local inflammatory reactions by altering adherence of neutrophils to endothelial surfaces (33) .
When MO, endothelial cells, and smooth muscle cells are stimulated to overproduce NO by circulating endotoxin, the physiologic disruptions that are characteristic of septic shock may ensue (34) . In addition, NO and other reactive nitrogen intermediates have direct microbistatic and microbicidal activities against a variety ofpathogens (16) (17) (18) (19) (20) (21) . In this report, evidence for an antiviral effect of NO is provided by its ability to inhibit HSV 1 replication.
The transformed murine macrophage cell line, RAW 264.7, is very permissive for HSV 1 replication until activated by yIFN and LPS (Table I) . Two functionally different inhibitors of NOS, L-NMMA and DPI, reduced the ability of activated RAW MO to suppress HSV 1 replication (Fig. 1) . The fact that neither of these inhibitors completely reversed the antiviral state in RAW MO induced with yIFN/LPS is consistent with the activation of other known inhibitors of HSV 1 in these cells including TNFa, 2'5'-oligoadenylate synthetase, and the PI /eIF-2a protein kinase (28) . When NO was also present in this pool of inhibitors, HSV 1 replication was more completely inhibited (Fig. 2) .
L-NMMA and DPI are not specific inhibitors of the nitric oxide synthetase. Arginine-dependent pathways other than the one that produces NO may be inhibited by L-NMMA and could be responsible for the antiviral effect in activated RAW Mo. However, evidence for an alternative antiviral argininedependent pathway in HEp2 cells treated with yIFN/LPS was not observed. Ofcourse, this observation does not exclude such a pathway in an activated murine macrophage.
An exogenous source ofNO facilitated a more direct assessment ofits effect on HSV 1 replication. In the absence of'yIFN and LPS, antiviral activity was observed in several cell lines exposed to SNAP (Fig. 3) . Despite a relatively short half-life (4 h), a single administration ofSNAP 3 h after infection reduced HSV 1 replication in each of three cell lines by 93-99%. Therefore, although the metabolic effects of NO may contribute to its antiviral activity, this mechanism also is likely to account for some of the antiviral properties of other host-response mediators such as interferon.
Cell viability was not impaired by NO at the concentrations and durations oftreatment used in this study. Interestingly, the viability of infected monolayers was unaltered by the addition of SNAP (or in activated RAW MO) despite the reduction in HSV 1 replication. Enhanced cytotoxicity of NO in the presence of HSV infection, or preserved cytopathic behavior of the virus despite a decline in the number of infectious particles, may account for this effect.
Cytostasis is a well-recognized effect of NO and was observed with each ofthe cell lines employed in these studies ( 16, 17, 21, 31 ) . Previous studies suggest that HSV replication may be impaired in growth-arrested cells, particularly when certain viral genes are defective, such as ICPO or ribonucleotide reductase (35, 36) . The latter enzyme accounts, in large part, for the dramatic rise in the intracellular pool of deoxynucleotides observed during a lytic HSV infection (37) . NO typically interacts with iron-containing proteins and, in the case ofribonucleotide reductase, interferes with its enzymatic function. Inhibition of several cellular ribonucleotide reductases by NO has been described and may account for some ofits cytostatic properties (38) . Like its cellular counterpart, the ribonucleotide reductase encoded by HSV has an iron moiety and is likely to be inhibited by NO. Although the HSV-encoded ribonucleotide reductase is not essential for viral replication in vitro, it is necessary under conditions where the intracellular pool of deoxynucleotides is in limited supply (36, 39, 40) . Inhibition ofthe cellular and viral ribonucleotide reductase might explain the sensitivity of HSV 1 to NO.
One of the most thoroughly studied effects of NO is its ability to activate the heme-containing enzyme, guanylate cyclase (41, 42) . Interaction of NO with the cytosolic form of guanylate cyclase stimulates the production ofcGMP which, in turn, mediates many well characterized intracellular events (13-15, 41, 42) . Little is known about the effect of cGMP on HSV replication. Elevations in cGMP delay reactivation of HSV 1 from its latent state in explanted murine sensory ganglia while cAMP accelerates reactivation (43, 44) . The role of cGMP in HSV-infected sensory neurons will need to be defined to more completely understand the role of NO in the pathogenesis of HSV infections. Viral, immune, and cellular factors may all contribute to the downregulation of lytic HSV 1 infections. Recent evidence suggests that the presence of the viral latency-associated transcripts may enhance the ability of HSV 1 to establish a latent infection in trigeminal ganglia (45) . The viral ribonucleotide reductase appears to be required for HSV to lytically infect and reactivate from sensory neurons (39, 40) . However, studies with engineered viral mutants deficient in latency-associated transcripts, ribonucleotide reductase, as well as many other loci demonstrate that these genes are not essential for the establishment of latency (40, (45) (46) (47) . Host immune responses play an important role in containing acute infections and probably help to prevent the clinical expression of HSV reactivations (1). However, even severe immune defects do not necessarily precipitate a recurrence of HSV infection. Therefore, neuronal characteristics are likely to be essential in modulating the status of HSV infection.
Nitric oxide seems well suited to play a role in the pathogenesis of HSV infections. HSV may come in contact with NO by infecting neurons that contain the constitutive form of NOS. This enzyme is found in a few percent of neurons in normal sensory ganglia (48) . However, up to 45% of neurons in rat dorsal root ganglia can express the neuronal NOS mRNA for at least 2 mo after nerve injury (49) . In addition, HSV may be exposed to cells with inducible NOS including resident cells in the nervous system (i.e., astrocytes, endothelial cells, and perhaps others) or infiltrating leukocytes (50) . As an endogenous inhibitor of ribonucleotide reductase, NO may contribute significantly to the balance that exists between the virus and its host neuron.
An understanding of how NO affects interactions between HSV and the host may have direct applications to other viruses. For example, other herpes viruses, including varicellazoster virus and EBV, have ribonucleotide reductase genes that may be targets for NO. Furthermore, other viruses that reside in cells ofthe immune and nervous systems (i.e., HIV, cytomegalovirus) may be subject to the influences of NO. Therefore, defining the influence that NO has on HSV 1 infection may provide useful insights into the pathogenesis of other viral infections.
